BioSpace News Archive

BioCapital

Statement From Stacey D. Stewart, President And CEO Of March Of Dimes, On New Federal Data Showing More Babies Being Born Too Soon For 4th Year In A Row

March of Dimes released the following statement from President and CEO Stacey D. Stewart regarding the new federal report on 2018 provisional birth data

May 15, 2019
·
4 min read
Business

Civica Rx and Xellia Pharmaceuticals Join Forces to Reduce Chronic Drug Shortages

Civica Rx (Civica, Inc.) and Xellia Pharmaceuticals today announced they have signed a product supply agreement under which Xellia will manufacture essential antibiotics, including Vancomycin and Daptomycin, for Civica’s member health systems.

May 15, 2019
·
5 min read
Takeda to Highlight New Research into the Long-term Complications of Chronic Hypoparathyroidism at the European Congress of Endocrinology 2019 Annual Meeting

Seven presentations will be shared, including new data on the risks of long-term cardiovascular, renal and infection complications, underlining Takeda’s commitment to further understanding of this rare disease

May 15, 2019
·
7 min read
Drug Development

GenSight Biologics Reports Positive 96-Week Data from REVERSE Phase III Clinical Trial of GS010 for the Treatment of Leber Hereditary Optic Neuropathy (LHON)

GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported a first set of results from Week 96 of the REVERSE Phase III clinical trial.

May 15, 2019
·
15 min read
Drug Development

Sensorion Announces the Positive Data Safety Monitoring Board (DSMB) Review and Continuation of the Phase 2 Clinical Trial for SENS-111 in Acute Unilateral Vestibulopathy (AUV)

Sensorion announced that the independent Data Safety Monitoring Board has undertaken a review of the safety data for the 76 first patients having completed the phase 2 clinical trial for SENS-111 in the treatment of acute unilateral vestibulopathy.

May 15, 2019
·
3 min read
Business

Q3 Medical Devices Limited Enters into a Distribution Agreement with Medtronic for its Biodegradable Biliary and Pancreatic Stent

Q3 Medical Devices Limited based in Dublin, Ireland, announced that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the first to market fully biodegradable biliary and pancreatic stent designed as an alternative to traditional plastic stents.

May 15, 2019
·
2 min read
Business

EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development

EUSA Pharma (EUSA), a global biopharmaceutical company focused on oncology and rare disease, today announced the strengthening of its senior leadership team with the appointments of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development

May 15, 2019
·
3 min read
Business

IBM and ERGO Aktiv are helping people after stroke

IBM and Neurorehabilitation Center ERGO Aktiv put together a virtual assistant for families dealing with situation after a stroke or other acquired brain damage.

May 15, 2019
·
3 min read
Hong Kong Science Park Leads Start-Up Delegation to North America’s Fastest Growing Technology Conference in Toronto

Fourteen park companies to showcase their innovations at the Collision Conference, alongside many of the world’s most disruptive emerging technology companies

May 15, 2019
·
11 min read
InteRNA and UMC Utrecht Publish Preclinical Evidence for Potential of miRNAs in Treatment of Epilepsy

InteRNA Technologies announced today the recent publication of data from a collaboration with University Medical Center (UMC) Utrecht in Journal of Neuroscience showing that the downregulation of miR-135a levels can reduce seizure activity after the onset of spontaneous recurrent seizures (SRS) in chronic-stage Mesial Temporal Lobe Epilepsy (mTLE) in mouse models

May 15, 2019
·
3 min read